VarCov Co’s Tyra Biosciences TYRA Stock Holding History

VarCov Co’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,708	Closed	-$255K	–	636
2025 Q4	$255K	Buy	+9,708	New	+$178K	0.1%	352

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

APMC

Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

VarCov Co's TYRA Position: Q1 2026 in Review

VarCov Co sold out of Tyra Biosciences (TYRA) in Q1 2026, closing a stake of 9,708 shares — an estimated $255K sold.

VarCov Co first reported a position in TYRA in Q4 2025 and held it in 1 quarter. The position peaked at $255K in Q4 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

VarCov Co reported no remaining Tyra Biosciences position as of Q1 2026 after selling out during the quarter.
VarCov Co sold 9,708 Tyra Biosciences shares in Q1 2026, an estimated $255K.
VarCov Co first reported a position in Tyra Biosciences in Q4 2025 and held it in 1 quarter.
VarCov Co's Tyra Biosciences position peaked at $255K in Q4 2025.
164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on VarCov Co's 13F filing for Q1 2026, filed 15 May 2026.